KOD KODIAK SCIENCES INC revenue, earnings and financials
For the quarter ended June 30, 2026, KODIAK SCIENCES INC reported revenue of n/a, net income of −$65.6M and diluted EPS of −$1.05; for the fiscal year ended December 2025 revenue was n/a.
KOD annual revenue and earnings
- Fiscal year ended Dec 2025: revenue n/a, gross profit n/a, operating income −$234M, net income −$230M (margin n/a), EPS −$4.32
- Fiscal year ended Dec 2024: revenue n/a, gross profit n/a, operating income −$187M, net income −$176M (margin n/a), EPS −$3.35
- Fiscal year ended Dec 2023: revenue n/a, gross profit n/a, operating income −$277M, net income −$260M (margin n/a), EPS −$4.97
- Fiscal year ended Dec 2022: revenue n/a, gross profit n/a, operating income −$341M, net income −$334M (margin n/a), EPS −$6.39
- Fiscal year ended Dec 2021: revenue n/a, gross profit n/a, operating income −$267M, net income −$267M (margin n/a), EPS −$5.16
KOD quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$65.6M, EPS −$1.05
- Quarter ended Mar 31, 2026: revenue n/a, net income −$58.2M, EPS −$0.94
- Quarter ended Dec 31, 2025 (from the annual report): revenue n/a, net income −$56.7M, EPS −$1.04
- Quarter ended Sep 30, 2025: revenue n/a, net income −$61.5M, EPS −$1.16
- Quarter ended Jun 30, 2025: revenue n/a, net income −$54.3M, EPS −$1.03
- Quarter ended Mar 31, 2025: revenue n/a, net income −$57.5M, EPS −$1.09
- Quarter ended Dec 31, 2024 (from the annual report): revenue n/a, net income −$44.1M, EPS −$0.83
- Quarter ended Sep 30, 2024: revenue n/a, net income −$43.9M, EPS −$0.84
- Quarter ended Jun 30, 2024: revenue n/a, net income −$45.1M, EPS −$0.86
- Quarter ended Mar 31, 2024: revenue n/a, net income −$43.0M, EPS −$0.82
- Quarter ended Dec 31, 2023 (from the annual report): revenue n/a, net income −$59.5M, EPS −$1.14
- Quarter ended Sep 30, 2023: revenue n/a, net income −$50.0M, EPS −$0.95
- Quarter ended Jun 30, 2023: revenue n/a, net income −$80.2M, EPS −$1.53
- Quarter ended Mar 31, 2023: revenue n/a, net income −$70.8M, EPS −$1.35
- Quarter ended Dec 31, 2022 (from the annual report): revenue n/a, net income −$70.4M, EPS −$1.35
- Quarter ended Sep 30, 2022: revenue n/a, net income −$77.0M, EPS −$1.47
- Quarter ended Jun 30, 2022: revenue n/a, net income −$90.6M, EPS −$1.74
- Quarter ended Mar 31, 2022: revenue n/a, net income −$95.7M, EPS −$1.83
- Quarter ended Dec 31, 2021: revenue n/a, net income −$93.2M, EPS −$1.79
- Quarter ended Sep 30, 2021: revenue n/a, net income −$67.5M, EPS −$1.30
KOD cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$136M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$117M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$154M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow −$206M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow −$182M, share buybacks n/a
KOD balance sheet
- Jun 30, 2026: cash $126M, total assets $257M, total liabilities $196M, shareholders' equity $61.1M
- Mar 31, 2026: cash $170M, total assets $306M, total liabilities $194M, shareholders' equity $112M
- Dec 31, 2025: cash $210M, total assets $352M, total liabilities $194M, shareholders' equity $157M
- Sep 30, 2025: cash $72.0M, total assets $218M, total liabilities $194M, shareholders' equity $23.7M
- Jun 30, 2025: cash $104M, total assets $257M, total liabilities $186M, shareholders' equity $70.3M
- Mar 31, 2025: cash $139M, total assets $298M, total liabilities $189M, shareholders' equity $109M
- Dec 31, 2024: cash $168M, total assets $336M, total liabilities $185M, shareholders' equity $150M
- Sep 30, 2024: cash $198M, total assets $373M, total liabilities $187M, shareholders' equity $185M
Is KOD profitable?
No. KODIAK SCIENCES INC lost $242M over the last four quarters.
What is KOD's EPS?
Diluted earnings per share over the last four quarters were −$4.19; −$1.05 in the latest quarter.